摘要
目的探讨康莱特注射液治疗原发性肝癌的疗效。方法对照组51例采用介入化疗,治疗组105例采用康莱特注射液静点治疗。结果治疗组癌灶缓解率(CR+PR)为11.42%,对照组为9.8%,治疗组症状改善总有效率为80.95%,对照组为25.49%,两组疗效比较有显著性差异(P<0.05)。结论对原发性肝癌,康莱特能明显改善症状,提高生存质量。
Objective To explore the efficacy of kanglaite injection in the treatment o! primary liver cancer （ PLC ） . Methods A total of 105 PLC patients were divided into two groups randomly ：study group treated by kanglaite injection and control group treated by chemotherapy. Resuets Effective rate （ CR ＋ PR ） in study group was 11.42% and in control group was 9.8%. Conduslon Kanglaite injection may improve the life quality and immune function of PLC patients.
出处
《现代肿瘤医学》
CAS
2006年第4期485-486,共2页
Journal of Modern Oncology
关键词
康莱特注射液
原发性肝癌
介入化疗
kanglaite injection
primary liver cancer
chemotherapy
